Scientists Identify Novel Therapeutic Compounds That can Prevent Neurodegeneration

by Rajashri on  October 30, 2008 at 4:41 PM Drug News
  •   Print
  •   Share
  •   Comments
  •  Text 
A class of compounds that can prevent degeneration of neurons, the underlying cause of conditions like Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS), has been identified by US researchers.

Researchers at the University of Texas at Dallas and Southern Methodist University insist that their study attains significance because current medications for such neurodegenerative diseases alleviate only their symptoms but not the underlying cause.

The researchers describe the compounds they have identified as 3-substituted indolones.

They have also conducted a structure-activity relationship study to identify substituent groups that are important for neuroprotective efficacy.

A previous study by the same group showed that one of these 3-substituted indolones, called GW5074, prevents neurodegeneration and improves behavioural outcome in a mouse model of neurodegeneration.

Dr. Santosh D'Mello, the study's senior author, said: "More recent but unpublished work by our group and Doris Kretzschmar, a collaborator at the Oregon Health and Science University, found that GW5074 and other related 3-substituted indolones are also protective in a fly model of Alzheimer's disease."

The current study has unveiled several compounds that are more efficacious than GW5074, and that do not display any cytotoxicity even when used at high doses.

Thus, say the researchers, these 3-substituted indolones are thus novel and promising candidate therapeutic agents for pre-clinical testing against human neurodegenerative conditions.

Dr. D'Mello said: "Studies into the mechanisms underlying neuronal apoptosis has identified several molecules that can be targeted in developing drugs to treat neurodegenerative diseases. Some of these have been tested in human clinical studies but have not proven to be effective at reducing neurodegeneration in patients. Our study has identified some 3-substituted indolones that might be suitable for development as therapeutic agents.

Page 1 Page 1 | 2  Next
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
X

Medwonders Health Network

  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
News Categories:  
Kidney Health Center

Drug Related News

» Schizophrenia Drug Differentiates Cancer Stem Cells into Less Threatening Cells » Docs Who Seldom Meet Drug Reps Continue to Prescribe Drugs With FDA “Black Box” Warnings
» Revision in Quality Standards for Heparin » Acne Drug Users At High Risk of Developing Eye Infections
» Patients Who Take Antidepressants When in ICU More Likely to Die » New Tablet Coating Product by Ideal Cures, In Geneva
» Prednisolone Benefits Patients With Bell's Palsy » 'Orphan' Sleep Drug may Fight Cancer
Read More >>